SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ¨ Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ | Preliminary Proxy Statement | |||
¨ | Confidential, For Use of the Commission Only (As Permitted by Rule 14a-6(e)(2)) | |||
¨ | Definitive Proxy Statement | |||
x | Definitive Additional Materials | |||
¨ | Soliciting Material under Rule 14a-12 | |||
CONSOLIDATED-TOMOKA LAND CO. | ||||
(Name of Registrant as Specified in its Charter) | ||||
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||||
Payment of Filing Fee (Check the appropriate box): | ||||
¨ | No fee required | |||
¨ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
(1) | Title of each class of securities to which transaction applies:
| |||
| ||||
(2) | Aggregate number of securities to which transaction applies:
| |||
| ||||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
| ||||
(4) | Proposed maximum aggregate value of transaction:
| |||
| ||||
(5) | Total fee paid: | |||
| ||||
¨ | Fee paid previously with preliminary materials. | |||
¨ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. | |||
(1) | Amount Previously Paid:
| |||
| ||||
(2) | Form, Schedule or Registration Statement No.:
| |||
| ||||
(3) | Filing Party:
| |||
| ||||
(4) | Date Filed:
| |||
|
WHY CONSOLIDATED-TOMOKA SHAREHOLDERS SHOULD VOTE WITH THE
BOARDS RECOMMENDATIONS AT THE ANNUAL MEETING
April 12, 2016
On March 15, 2016, Consolidated-Tomoka Land Co. (CTO or the Company) distributed a proxy statement (the Proxy Statement) for its annual meeting of shareholders, to be held on April 27, 2016. In the Proxy Statement, shareholders were asked to vote on the following proposals:
1. | to elect the seven director nominees listed in the Proxy Statement, |
2. | to ratify the appointment of Grant Thornton LLP as the Companys independent auditor, |
3. | to approve an advisory vote on executive compensation, |
4. | to vote on a shareholder proposal submitted by Wintergreen Advisers, LLC (Wintergreen Advisers) to request that the Companys Board of Directors (the Board) hire an independent advisor to evaluate ways to maximize shareholder value; and |
5. | to vote on a proposal to approve the issuance of additional shares of common stock upon conversion of our 4.50% Convertible Senior Notes due 2020. |
On April 6, 2016, Wintergreen Advisers, the Investment Manager of Wintergreen Fund, Inc. (Wintergreen Fund and, together with Wintergreen Advisers and their affiliates, Wintergreen) published a statement indicating that Wintergreen intends to vote against every director nominee and every proposal except its own shareholder proposal. Our bylaws require that director nominees who do not receive a majority of the votes cast on their election resign from the Board. Wintergreen Advisers is attempting to threaten CTO with a governance crisis by seeking to remove all of our directors, despite the Companys superior performance in executing its business strategy. Wintergreen is doing this even though in March of last year, in Wintergreen Funds 2014 annual report, Wintergreen Advisers was highly complimentary of CTOs performance and management. What changed?
While our Board is in support of reviewing strategic alternatives to maximize shareholder value, we believe that Wintergreens strategy is to force a sale or liquidation of CTO for its own benefit, rather than the interests of all of CTOs shareholders. The total number of CTO shares owned by Wintergreen is approximately 70 times CTOs current average daily trading volume. This suggests that Wintergreen could not sell its CTO shares through market trades within a reasonable time and without substantial adverse impact on CTOs share price, rendering its CTO stake relatively illiquid. Wintergreen Fund has declined in size (from $1.5 billion in net assets at the beginning of 2015 to approximately $700 million at the end of 2015, according to Wintergreen Funds 2015 Annual Report) while its relatively illiquid investment in CTO has remained unchanged. According to Wintergreen Funds own publicly available information, Wintergreen Funds CTO shares were its ninth largest holding at December 31, 2014, but were its second largest holding at December 31, 2015 (at approximately 9.3% of its assets under management). We suspect that the illiquidity of Wintergreens CTO stake may create a problematic situation for Wintergreen Fund, for which Wintergreens solution is to agitate for the sale or liquidation of CTO.
As CTOs Board, we seek at all times to maximize shareholder value. We believe that our 101.8% total return from December 31, 2011 to November 19, 2015, the day before Wintergreen Advisers first public attack letter on November 20, 2015, shows our ability to do just that, by pursuing and executing the business strategy that we have consistently articulated in our public filings. In November 2015, we received Wintergreen Advisers submission of a shareholder proposal for the Company to hire a financial advisor to identify ways to maximize shareholder value. Shortly thereafter, our Board held a special meeting at which Wintergreen Advisers proposal was approved for inclusion in the Proxy Statement, and the Board formed a committee of independent directors (the Independent Committee) to hire an independent financial advisor for that purpose. After a thorough process involving proposals from nine investment banking firms, in February 2016 the Independent Committee hired Deutsche Bank Securities Inc. (Deutsche Bank) to advise it as to CTOs strategic alternatives. The Independent Committee and Deutsche Bank are conducting a careful and thorough analysis of ways to maximize shareholder value. We will provide an update at our annual meeting on April 27, 2016.
In recent months, Wintergreen has consistently claimed that the Companys share price has declined not because of Wintergreens campaign to disparage our Board and our management team, and its attempt to force a sale or liquidation, but because of the Companys actions. In fact, the Company has a record of great success in recent years, as outlined in this letter. As we have continued to pursue our business strategy, we can point with pride to our achievement of land sales and earnings growth. Our Board, a majority of whom were originally recruited and nominated by Wintergreen Advisers, has rejected Wintergreens claims and consistently and repeatedly has expressed its full support for management.
We believe that Wintergreens public attacks on the Company have only hindered our efforts to maximize shareholder value. In a series of letters since November, Wintergreen has asserted a wide variety of claims that management has violated its duties to shareholders. Our Audit Committee and other committees of independent directors, most of them originally recruited and nominated by Wintergreen, have retained independent counsel and independent accountants, and have devoted significant time and expense looking into each claim. To date, the Company has incurred approximately $1 million of costs associated with the investigations of all of Wintergreens claims. None of Wintergreens claims have been found to have any basis or merit. We believe, however, that Wintergreens allegations have undermined public perceptions of the Companys value by creating the impression that the Company may be forced to sell its assets in a fire sale, which we believe would not be in the best interests of the shareholders.
Wintergreen Advisers now states that it will vote against all of our directors and our independent auditor because of its baseless claims. Let us now examine Wintergreens planned proxy votes:
1. | Wintergreen will vote against all of our directors, a majority of whom were originally recruited and nominated by Wintergreen. Our bylaws require that directors who do not receive a majority of the votes cast on their election must resign. Wintergreen seeks to |
force the resignation of our entire board, including its own nominees, apparently thinking that this will make the sale of the Company more likely. Instead, our shareholders would suffer significant harm. We recommend that the shareholders vote in favor of all of the seven director nominees listed in the Proxy Statement. |
2. | Wintergreen will vote against ratification of the appointment of Grant Thornton as our independent registered public accounting firm. Grant Thornton is a widely known and respected public accounting firm, and we know of no reason why we should replace Grant Thornton. Our Board and Audit Committee fully support Grant Thornton and recommend that shareholders vote to ratify its selection. |
3. | Wintergreen will vote against approval of the compensation of the named executive officers. Wintergreen has made inflammatory and inaccurate claims that John Albrights compensation has increased by over five times his 2014 compensation. Wintergreen fails to note that Mr. Albrights base compensation and bonuses from 2014 to 2015, in the aggregate, increased less than 2% and that the primary cause of the increase in compensation shown in the Proxy Statement is the estimated value that the equity incentive grants received by Mr. Albright in 2015 would have if all the grants vested. The majority of Mr. Albrights equity incentive grants are restricted shares that will vest only if the Companys stock price appreciates significantly. These incentives align Mr. Albrights compensation with increases in shareholder value through stock appreciation. |
Wintergreen blames the Companys recent share price performance on management. Our Board rejects this claim. Management has successfully pursued a business strategy that has caused our net income and net income per share to double over the last two years, and has caused our total operating income to triple over that period. Further, the Company, under the current management team, has executed through March 31, 2016, 16 land sales (five of which have projects under construction) for total proceeds exceeding $37 million, and has a current pipeline of transactions that would generate an additional $54 million in proceeds, if completed. Our Board and Compensation Committee recommend that the shareholders vote to approve the compensation of our executive officers.
4. | Wintergreen will vote not to authorize the issuance of shares of common stock upon conversion of the Companys 4.50% Convertible Senior Notes due 2020 (the Convertible Notes). When we issued the Convertible Notes in March 2015, we agreed to seek shareholder approval to allow the Company the flexibility to issue, upon conversion of the Convertible Notes, shares in excess of 20% of our shares outstanding. As mentioned in our most recent annual report, however, the Company intends to settle the Convertible Notes in cash upon conversion with any excess conversion value to be settled in shares of our common stock. Our Board recommends authorization of the issuance of additional shares of common stock upon conversion of the Convertible Notes. |
Wintergreen has argued that the Company should use the proceeds from recent property sales to pay down debt. Use of these proceeds to pay down debt, however, would expose the Company to significant tax liability and would be contrary to the objective of
maximizing shareholder value, as we would be repaying the debt with after-tax dollars. The property sales, consistent with our business strategy, have been made as part of a tax-free exchange structure that defers realization of taxable gain pursuant to Section 1031 of the Internal Revenue Code.
As described in this letter, we have had great success executing our strategic business plan. With the ongoing support of our shareholders, we will continue to pursue a strategy that has generated significant value for the Company and a 101.8% total return from December 31, 2011 to November 19, 2015, the day before Wintergreen Advisers first public attack letter.
At the same time, the Board will assist and support the Independent Committees efforts with Deutsche Bank to find strategic alternatives to maximize shareholder value.
We ask that you vote your CTO shares as recommended by the Board.
You may vote your shares by following the instructions on the notice of availability of proxy materials which you previously received; or, if applicable, by completing and returning the proxy card included with your Proxy Statement. Should you need assistance in casting your vote, feel free to call our proxy solicitor Georgeson LLC toll-free at 1-800-905-7281.
ON-LINE ANNUAL MEETING MATERIALS:
www.investorvote.com/CTO
Your vote is important!
The Board of Directors of Consolidated-Tomoka Land Co.
Jeffry B. Fuqua, Chairman
FORWARD-LOOKING STATEMENTS
Certain statements contained in this document are forward-looking statements. Words such as believe, estimate, expect, intend, anticipate, will, could, may, should, and similar expressions identify certain of such forward-looking statements, which speak only as of the dates on which they were made. Although forward-looking statements are made based upon managements expectations and beliefs concerning future developments and their potential effect upon the Company, a number of factors could cause actual results to differ materially from those set forth in the forward-looking statements. Such factors may include uncertainties associated with the closing of planned property sales, the possible strategic alternatives that might be identified during the Companys review of strategic alternatives, and the other uncertainties and risk factors discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015 as filed with the Securities and Exchange Commission. There can be no assurance that future developments will be in accordance with managements expectations or that the effect of future developments on the Company will be those anticipated by management.